Hidekazu Hiramoto

3PUBLICATIONS
0CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 26, 2018
Publisher Correction: miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein.

Erina Tonouchi, Yasuyuki Gen, Tomoki Muramatsu

|Mar 16, 2018
miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein.

Erina Tonouchi, Yasuyuki Gen, Tomoki Muramatsu

|Jun 23, 2017
miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer.

Hidekazu Hiramoto, Tomoki Muramatsu, Daisuke Ichikawa

Pageof 1

Frequent Collaborators